Furthermore, the expression of PD‐L1 is significantly increased in the tumors of RC patients who have received NCRT [16, 41], and a low PD‐L1 tumor proportion score was associated with inferior survival in RC patients undergoing NCRT [42]. This evidence concerns the gene CD274 and neoplasm.